BEUDAMED
    FDA Adverse Event Injury Summary report: N

    MICROMATRIX

    MDR report key: 11657142 · Received April 13, 2021

    Report

    Report Number
    3005920706-2021-00001
    Event Type
    Injury
    Date Received
    April 13, 2021
    Report Date
    April 12, 2021
    Manufacturer
    ACELL, INC.
    Product Code
    KGN
    UDI-DI
    00386190001141
    PMA / PMN Number
    K172399
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CA, US
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    THIS MDR IS BEING SUBMITTED BECAUSE OF A REPORTED ADVERSE EVENT AFTER INITIAL APPLICATION OF THE ACELL DEVICE. HOWEVER, THE DEVICE DID NOT MALFUNCTION AND LIKELY DID NOT CONTRIBUTE TO THE PATIENT ISSUE. AS PER (B)(4): MICROMATRIX PRODUCT SPECIFICATION, MICROMATRIX IS STERILIZED TO SAL10^-6 USING ELECTRON BEAM IRRADIATION STERILIZATION PROCESS; THE MANUFACTURING PROCESS IS VALIDATED TO PRODUCE DEVICES THAT HAVE A VIRAL LOAD OF LESS THAN ONE INFECTIOUS PARTICLE PER 10^6 DEVICES; AND EVERY BATCH OF DEVICE IS ALSO TESTED FOR THE PRESENCE OF ENDOTOXIN TWICE (IN-PROCESS AND FINAL DEVICE POST STERILIZATION). AS PER (B)(4): MICROMATRIX IFU, IT IS INTENDED FOR ONE TIME USE, IS PRESCRIPTION ONLY, AND SHOULD ONLY BE APPLIED BY A TRAINED PHYSICIAN. ADDITIONALLY, THE DEVICE IFU INSTRUCTS THE USER TO ONLY HYDRATE THE DEVICE WITH SALINE AND TO DISCARD ANY UNUSED PORTION OF THE DEVICE. THE STABILITY OF THE ANTIBIOTIC SOLUTION AND THE MICROMATRIX IN THE "BALM" IS UNKNOWN, NOR ARE THE TECHNIQUE AND ENVIRONMENTAL CONDITIONS IN WHICH THE PATIENT SELF-APPLIED THE "BALM" POST-OPERATIVELY. THIS IS AN OFF-LABEL USE OF THE DEVICE FOR A PROCEDURE NOT LISTED IN THE IFU. A REVIEW OF THE MANUFACTURING RECORDS FOR THIS LOT SHOWED THAT THE DEVICE WAS MANUFACTURED IN COMPLIANCE WITH ACELL'S OPERATING PROCEDURES; FEDERAL, STATE, AND LOCAL LAWS AND REGULATIONS; AND MET ALL SPECIFICATION AND DISTRIBUTED STERILE.

    Description of Event or Problem · 1

    A PATIENT WHO WAS TREATED WITH MICROMATRIX AT HAIR TRANSPLANT HARVEST SITE, HAS COMPLAINED ABOUT HAVING MULTIPLE EPISODES OF BACTERIAL AND VIRAL INFECTIONS AFTER THE ORIGINAL HAIR TRANSPLANT WOUND SITE HEALED. THE PROCEDURE HAPPENED 9 TO 12 MONTHS AGO. DOCTOR WHO PERFORMED THE PROCEDURE, MIXED THE MICROMATRIX WITH TRIPLE ANTIBIOTIC OINTMENT (BRAND NOT KNOWN) APPLIED IT TOPICALLY TO THE HARVEST SITE. DOCTOR ALSO PROVIDED SOME OF THIS MIXTURE, KNOWN BY NAME "BALM" TO THE PATIENT TO USE THREE TIMES A DAY AT HOME. PATIENT WOUND BED HAS HEALED AND HE IS NO LONGER APPLYING "BALM". HOWEVER, THE PATIENT STARTED HAVING INFECTION APPEAR AT DIFFERENT PLACES OVER HIS BODY (OUTSIDE OF THE ORIGINAL WOUND SITE) IN THE FORM OF PUSTULE. PATIENT SPECIFICALLY MENTIONED ONE OF THOSE INCIDENT WHEN PUSTULE POPPED UP IN HIS LEG AND IT WAS VERY DEBILITATING. THE PAIN WAS EXCRUATING (10 OUT OF 10) AND THE PATIENT WAS ON BED FOR A WEEK. THE PATIENT VISITED DIFFERENT DOCTORS (DERMATOLOGISTS), AND ONE OF THEM PERFORMED BIOPSY ON THE CONTENT FROM THE PUSTULE AND IT CAME POSITIVE FOR FUNGUS (SPECIES NOT DISCLOSED). DOCTOR ALSO CULTURED THE CONTENT FROM THE PUSTULE AND IT CAME POSITIVE FOR BACTERIA (SPECIES NOT DISCLOSED). WHEN INFECTION APPERAED, DOCTOR TREATED THE PATIENT WITH ORAL ANTIBIOTICS (NAME/ TYPE NOT KNOWN).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    556545 MICROMATRIX MICROMATRIX KGN ACELL, INC. MM0060 018089 00386190001141

    Patients

    Seq Age Sex Outcome Treatment
    1 0 YR Other